Reagents and consumables for Roche immunostainers
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
NATIONAL INSTITUTES OF HEALTH OLAO
Contract Value
Not provided
Codes & Classification
Solicitation Number
75N98027Q00026
NAICS
325413 - In-Vitro Diagnostic Substance Manufacturing
Classification Code
6640
Additional Details
Documents3
The National Institutes of Health (NIH), Office of Logistics and Acquisition Operations (OLAO), has issued a Combined Synopsis/Solicitation for the procurement of reagents and consumables specifically designed for Roche immunostainers. This opportunity, identified by procurement number 75N98027Q00026, is intended to support ongoing laboratory operations at the NIH facility located in Bethesda, Maryland.
The primary purpose of this procurement is to secure a reliable supply of in-vitro diagnostic substances and related consumables that are compatible with Roche immunostaining equipment. These materials are essential for the NIH’s research and diagnostic activities, ensuring the continuity and integrity of immunostaining processes critical to biomedical investigations. The scope of the contract encompasses the provision of estimated quantities of reagents and consumables, as detailed in the attached documents, which are expected to meet the operational needs of the NIH laboratories throughout the contract lifecycle.
Key requirements include the supply of high-quality, Roche-compatible reagents and consumables, delivered in accordance with the estimated quantities provided. Offerors must demonstrate their ability to consistently provide these products, adhering to the standards set forth in the solicitation. The procurement falls under NAICS code 325413 (In-Vitro Diagnostic Substance Manufacturing), with a product service code of 6640, indicating a focus on laboratory equipment and supplies.
The contracting entity is the NIH OLAO, a federal office within the Department of Health and Human Services. The place of performance is Bethesda, Maryland, ensuring that all deliveries and services are rendered at the NIH’s primary research campus. The solicitation is active and open for responses, with a submission deadline of November 18, 2026, at 13:11. Interested parties are encouraged to review the attached Combined Synopsis/Solicitation, estimated quantities, and Questions and Answers for comprehensive details regarding the requirements and expectations.
For further information or clarification, prospective contractors may contact Luz Casey at [email protected]. The opportunity is listed on SAM.gov under Opportunity ID 3feaa20cd9cb4dc1bf63f2c7fe640ebe, where additional attachments and updates may be accessed.
This procurement represents a stable, ongoing requirement for specialized laboratory consumables, and is well-suited for suppliers with proven experience in manufacturing and distributing in-vitro diagnostic substances compatible with Roche immunostainers. Contractors should ensure their offerings align with the technical specifications and delivery expectations outlined by the NIH to be considered for award.